Grippferon nasal spray 10ml

Indications

Prevention and treatment of influenza and acute respiratory viral infections (ARVI) in children and adults.

Dosing regimen

At the first signs of the disease Grippferon ^® apply for 5 days:

- at the age of 0 to 1 year, inject 1 dose (500 ME) into each nasal passage 5 times / day (single dose of 1000 ME, daily dose of 5000 ME);

- at the age of 1 to 3 years, 2 doses are injected into each nasal passage 3-4 times / day (single dose of 2000 ME, daily dose of 6000-8000 ME);

- at the age of 3 to 14 years, 2 doses are injected into each nasal passage 4-5 times / day (single dose of 2000 ME, daily dose of 8000-10000 ME);

- from the age of 15, and adults inject 3 doses into each nasal passage 5-6 times / day (single dose of 3000 ME, daily dose of 15000-18000 ME).

In order to prevent SARS and flu:

- upon contact with the patient and / or during hypothermia, the drug is injected in a single age dosage 2 times / day once;

- with a seasonal increase in the incidence of the drug is injected in the age dosage once in the morning with an interval of 24-48 hours.

If necessary, preventive courses are repeated.

To administer the drug, remove the protective cap, insert the spraying device into the nasal passage and press the spray mechanism strongly (1 dose - 1 press). Before the first application, you should press the spray mechanism several times until a spray cloud appears.

Contraindications

- individual intolerance to Interferon preparations and components that make up the preparation;

- severe forms of allergic diseases.

Use during pregnancy and lactation

Grippferon^® approved for use during the entire period of pregnancy. There are no restrictions for use during lactation.

Use in children

Possible use in children according to indications.

special instructions

The drug does not affect the ability to drive vehicles and mechanisms.

Overdose

Data overdose of the drug is not available.

Drug interaction

The use of intranasal vasoconstrictor drugs with Grippferon^® It is not recommended, as it contributes to the additional drying of the nasal mucosa.

Pharmacy sales terms

The drug is approved for use as a means of OTC.

Terms and conditions of storage

The drug should be kept out of reach of children at a temperature of 2 ° C to 8 ° C.